Cardiovascular risk stratification in obstructive sleep apnea: a potential role for cardiac troponins
SLEEP · 14.08.2026 · 49 (8)
DOI: 10.1093/sleep/zsag138 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLEEP, online erschienen am 21.05.2026. Verfasst von Bhajan Singh. Beteiligte Einrichtung: Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Personalized treatment of obstructive sleep apnea (OSA) can be enhanced by identifying patients who are at greatest risk of long-term complications such as cardiovascular disease
Autor:innen und Institutionen
- Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
- School of Human Sciences, University of Western Australia, Crawley, WA 6009, Australia.
- West Australian Sleep Disorders Research Institute, QEII Medical Centre, Nedlands, WA 6009, Australia.
ORCID-Profile: Bhajan Singh
Zitieren
APA
Singh, B. (2026). Cardiovascular risk stratification in obstructive sleep apnea: a potential role for cardiac troponins. SLEEP, 49(8). https://doi.org/10.1093/sleep/zsag138
Vancouver
Singh B. Cardiovascular risk stratification in obstructive sleep apnea: a potential role for cardiac troponins. SLEEP. 2026;49(8). doi:10.1093/sleep/zsag138
BibTeX
@article{Singh2026,
author = {Singh, Bhajan},
title = {Cardiovascular risk stratification in obstructive sleep apnea: a potential role for cardiac troponins},
journal = {SLEEP},
year = {2026},
volume = {49},
number = {8},
doi = {10.1093/sleep/zsag138}
}
EUVIMED